An Ignoble Experiment: Introducing Molecular Therapy - Oncolytics: Open for Submissions

2014/10/31

Introducing Molecular Therapy - Oncolytics: Open for Submissions

If you are unable to see the message below, click here to view.

Molecular Therapy – Oncolytics is an international, online-only open access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. While providing a unique forum for work in the fields of oncolytic virotherapy and T cell-based, and stem cell-based therapies, the journal will consider all top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses, other microorganisms, vaccination, or by transfer of cells and/or genes. The journal is now open for submissions.

To receive the very latest articles and developments in your field, sign up to receive e-alerts.

Submit your next manuscript to Molecular Therapy – Oncolytics and benefit from:

Molecular Therapy – Oncolytics is an official journal of the American Society of Gene & Cell Therapy
Reputation: the journal builds upon the success of Molecular Therapy and its sibling journals Molecular Therapy — Nucleic Acids and Molecular Therapy — Methods & Clinical Development
Assurance of the highest possible publishing, editorial and production standards
High visibility for your research: a recent study indicates that open access articles are viewed three times more often than articles only available to subscribers*
Wide dissemination: articles are published under a Creative Commons License, permanently and freely available for all to read, use and cite without restriction
Rapid peer review and online publication times
An online submission system, developed to speed up the submission process
Compliance with many open access funder mandates
Global reach through nature.com and widely distributed journal e-alert messages